SEC Form 4 · accession 0001127602-18-009292
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman & CEO · Director
Period of report
Feb 27, 2018
Accepted (ET)
Mar 1, 2018 · 12:11 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2018 | M | 21,577 | $76.70 | A | 325,517 | D | |
| Common Stock | Feb 27, 2018 | S | 300 | $107.45 | D | 325,217 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.48 | D | 325,117 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.56 | D | 325,017 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.565 | D | 324,917 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.57 | D | 324,817 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.575 | D | 324,717 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.58 | D | 324,617 | D | |
| Common Stock | Feb 27, 2018 | S | 30 | $107.59 | D | 324,587 | D | |
| Common Stock | Feb 27, 2018 | S | 200 | $107.595 | D | 324,387 | D | |
| Common Stock | Feb 27, 2018 | S | 23 | $107.615 | D | 324,364 | D | |
| Common Stock | Feb 27, 2018 | S | 77 | $107.625 | D | 324,287 | D | |
| Common Stock | Feb 27, 2018 | S | 200 | $107.64 | D | 324,087 | D | |
| Common Stock | Feb 27, 2018 | S | 200 | $107.65 | D | 323,887 | D | |
| Common Stock | Feb 27, 2018 | S | 70 | $107.655 | D | 323,817 | D | |
| Common Stock | Feb 27, 2018 | S | 400 | $107.67 | D | 323,417 | D | |
| Common Stock | Feb 27, 2018 | S | 110 | $107.69 | D | 323,307 | D | |
| Common Stock | Feb 27, 2018 | S | 500 | $107.71 | D | 322,807 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.735 | D | 322,707 | D | |
| Common Stock | Feb 27, 2018 | S | 300 | $107.76 | D | 322,407 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.77 | D | 322,307 | D | |
| Common Stock | Feb 27, 2018 | S | 200 | $107.79 | D | 322,107 | D | |
| Common Stock | Feb 27, 2018 | S | 100 | $107.80 | D | 322,007 | D | |
| Common Stock | Feb 27, 2018 | S | 300 | $107.81 | D | 321,707 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $76.67 | Feb 27, 2018 | M | 21,577 | D | Feb 27, 2016 | Feb 27, 2020 | Common Stock | 21,577 | 21,577 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.